BIOMAT Database Logo BIOMAT Database Logo

Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. 1985

A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut

Post-dexamethasone cortisol and platelet monoamine oxidase (MAO) activity levels were examined in 50 depressed patients. The incidence of non-suppression was significantly greater in patients with high platelet MAO activity than in those with low activity. Similar results were obtained when males and females were analysed separately. The mean 4 p.m. post-dexamethasone cortisol level was significantly higher in those patients who had high MAO activity than in their low MAO counterparts. Moreover, a statistically significant positive correlation was observed between platelet MAO activity and 4 p.m. post-dexamethasone cortisol levels.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
DST results and platelet MAO activity.
December 1985, The British journal of psychiatry : the journal of mental science,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
May 1982, The American journal of psychiatry,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.
January 1985, Journal of psychiatric research,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Elevated platelet MAO activity in schizophrenia-related depressive disorders.
January 1978, The American journal of psychiatry,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
[DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
October 1985, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Platelet MAO activity in clinical subtypes of depression and DST suppression.
May 1987, Acta psychiatrica Scandinavica,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.
April 1982, The American journal of psychiatry,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
[Blood platelet MAO activity in endogenous depressive syndrome].
January 1980, Psychiatria polska,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Serum DBH and platelet MAO in patients with depressive disorders.
January 1981, Pharmacopsychiatria,
A F Schatzberg, and A J Rothschild, and B Gerson, and J E Lerbinger, and J J Schildkraut
Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.
March 1989, Archives of general psychiatry,
Copied contents to your clipboard!